Keywords: کارسینوم Thymic; cartilage; dog; thymic carcinoma; thymic epithelial cell
مقالات ISI ترجمه شده کارسینوم Thymic
مقالات ISI کارسینوم Thymic (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارسینوم Thymic; Clinical trials; Mesothelioma; Non-small-cell lung cancer; Small cell lung cancer; Thymic carcinoma;
Keywords: کارسینوم Thymic; Thymus; Adenocarcinoma; Immunohistochemistry; Thymoma; Thymic carcinoma;
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Adjuvant radiation; Postoperative radiotherapy; National Cancer Data Base;
Keywords: کارسینوم Thymic; Thymic carcinoma; Mesothelin; Immunohistochemistry; Therapeutic target; Immunotherapy;
Keywords: کارسینوم Thymic; Tumeurs thymiques; Thymome; Carcinome thymique; Chimiothérapie; Chirurgie; Thymoma; Thymic carcinoma; Chemotherapy; Surgery;
Keywords: کارسینوم Thymic; Thymomas; Thymic carcinoma; Diagnosis; Surgery; Radiotherapy; Chemotherapy; Targeted therapies;
Keywords: کارسینوم Thymic; Thymic tumors; Thymic carcinoma; Thymic neuroendocrine tumors; Lymph node metastases; SEER registry;
Keywords: کارسینوم Thymic; Chemotherapy; Rare cancer; Refractory; Response; Survival; Thymic carcinoma;
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Thymic epithelial neoplasm; Staging
Keywords: کارسینوم Thymic; Lymphoma; Leukemia; Myasthenia gravis; Thymus cancer; Thymic carcinoma;
Keywords: کارسینوم Thymic; Thymic carcinoma; Surgery; Masaoka staging system; Prognosis
Keywords: کارسینوم Thymic; Thymic carcinoma; Invasive thymoma; Chemotherapy; Amrubicin; Phase II
Keywords: کارسینوم Thymic; Thymic carcinoma; Weekly chemotherapy; Induction chemotherapy; CODE; cisplatin, vincristine, doxorubicin, and etoposide; CT; computed tomography; MRI; magnetic resonance imaging;
Keywords: کارسینوم Thymic; Thymic carcinoma; Masaoka staging
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Thymic carcinoid; Database; Thymic malignancies;
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Methylation; Chromosomal abnormalities; Gene expression; Sequencing; Gene signatures
Keywords: کارسینوم Thymic; Thymic carcinoma; Squamous cell carcinoma; Targeted next-generation sequencing; Genetic profiling; Tyrosine kinase gene mutation; Heterogeneous;
Keywords: کارسینوم Thymic; Thymic carcinoma; Thymus; Masaoka staging system; Myasthenia Gravis; Surgery; Outcome;
Keywords: کارسینوم Thymic; Thymic carcinoma; Survival; Prognostic factor; Rare cancer; Surgery; Radiotherapy; Chemotherapy
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Staging system; TNM classification; History; Thymus; Masaoka staging system;
Keywords: کارسینوم Thymic; Thymic carcinoma; Staging; Prognostic factors; Thymic tumors; Surgery
Keywords: کارسینوم Thymic; Opsoclonus; Cerebellar ataxia; Thymic carcinoma; Paraneoplastic neurological syndrome; Onconeural antibodies; Surgical removal;
Keywords: کارسینوم Thymic; Thymic carcinoma; Prognostic significance; Chemotherapy; Metastasis; Thymic epithelial neoplasm;
Keywords: کارسینوم Thymic; Thymoma; Mediastinal disease; Thymic carcinoma; Statistics; Outcomes; Recurrence
Keywords: کارسینوم Thymic; Thymic carcinoma; Chemotherapy; Investigational drugs; Genetic profile; Next-generation sequencing
An immunohistochemical panel consisting of EZH2, C-KIT, and CD205 is useful for distinguishing thymic squamous cell carcinoma from type B3 thymoma
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; EZH2; C-KIT; CD205; Immunohistochemistry;
Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; PD-L1; IDO; FOXP3;
Thymic tumors and results of radiotherapy
Keywords: کارسینوم Thymic; TET; thymic epitelial tumor; TC; thymic carcinoma; NEC; thymic neuroendocrin carcinoma; OS; overall survival; DFS; disease-free survival; R0; complete resection; R+; incomplete resection; R1; microscopic residual disease; R2; macroscopic residual disease;
Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database
Keywords: کارسینوم Thymic; Thymic epithelial tumor; Thymoma; Thymic carcinoma; Paraneoplastic; Myasthenia gravis;
Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Immunotherapy; Intratumoral heterogeneity;
Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group
Keywords: کارسینوم Thymic; Thymic carcinoma; Clinical management; Survey; Multimodality therapy;
Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs)
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Gene mutations; c-KIT; PD-L1;
Expression of cathepsins V and S in thymic epithelial tumors
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Cathepsin V; Cathepsin S; Diagnostic marker;
Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Staging; Classification; Histopathology;
Loss of p16INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas
Keywords: کارسینوم Thymic; p16INK4A; CDKN2A; Thymic carcinoma; Fluorescence in situ hybridization;
Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
Keywords: کارسینوم Thymic; Thymic epithelial tumor; Thymoma; Thymic carcinoma; Postoperative radiotherapy; Network; Classification;
Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Treatment response; RECIST;
LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
Keywords: کارسینوم Thymic; Thymic carcinoma; Anticancer drug; Transporter;
Original articleDiagnostic roles of MUC1 and GLUT1 in differentiating thymic carcinoma from type B3 thymoma
Keywords: کارسینوم Thymic; MUC1; GLUT1; Thymic carcinoma; Type B3 thymoma; Differential diagnosis;
Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: Early response and toxicity assessment
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Proton therapy; Cardiac toxicity
Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network
Keywords: کارسینوم Thymic; Sunitinib; Thymic carcinoma; Thymoma; Second line
Concurrent thymoma, thymic carcinoma, and T lymphoblastic leukemia/lymphoma in an anterior mediastinal mass
Keywords: کارسینوم Thymic; Thymus; Thymoma; T lymphoblastic leukemia/lymphoma; Thymic carcinoma
A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; Saracatinib; AZD0530; Src inhibition;
Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems
Keywords: کارسینوم Thymic; Desmoglein 3; p40; Thymoma; Thymic carcinoma; Squamous carcinoma;
Pemetrexed in patients with thymic malignancies previously treated with chemotherapy
Keywords: کارسینوم Thymic; Pemetrexed; Chemotherapy; Thymoma; Thymic carcinoma; Thymic malignancy; Second-line or beyond chemotherapy
Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma
Keywords: کارسینوم Thymic; Thymoma; Thymic carcinoma; PD-1; PD-L1; Immunohistochemistry; Clone E1L3N;
Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes
Keywords: کارسینوم Thymic; Thymic carcinoma; Thymoma; Immuno-histochemistry; Glut-1
Massively Parallel Sequencing Identifies Recurrent Mutations in TP53 in Thymic Carcinoma Associated with Poor Prognosis
Keywords: کارسینوم Thymic; Next-generation sequencing; Thymoma; Thymic carcinoma;
Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas
Keywords: کارسینوم Thymic; Bcl-2; Ki-67 labeling index; Mitoses; Thymoma; Thymic carcinoma;